MUMBAI: Pharma firm, Strides ArcolabBSE 1.10 % today announced that it has received approval from the United States Food & Drug Administration (USFDA) for marketing of Tacrolimus capsules, used as immuno-suppressant.
"We have received approval from the USFDA for Tacrolimus capsules USP, 0.5 mg, 1 mg, and 5 mg and (they) will be launched immediately," company statement said here.
The product will be manufactured at the company's oral dosage facility at Bangalore and mark ..
"We have received approval from the USFDA for Tacrolimus capsules USP, 0.5 mg, 1 mg, and 5 mg and (they) will be launched immediately," company statement said here.
The product will be manufactured at the company's oral dosage facility at Bangalore and mark ..
This post is very nice and pretty well maintained. thanks for the post,keep updating.
ReplyDeletemycophenolate tablet
Its really a great post and deeply researched by author, its quiet impressive, really appreciated for the blog and keep updating your new post.
ReplyDeletepre and probiotic tablets